That's what is wrong with this CEO, everything is behind the scenes. Need to see direction defined for shareholders. Nothing else is going to move this PPS. Just waiting to get back to break even. GL with that!
they could easily announce they've sold out their latest funding block at any time. They have that Chinese conference coming up and who knows what else.
Wonder what announcing a $5 million capital raise would do to this stock's value?...
This is all before Phase II trials. If and when they get that far, the potential value of Prolanta really jumps, by the progress with the science if nothing else. They've reported that the capital they're looking to raise now is for Phase II trials which should be a pretty good indication that the current human trials are progressing well. (redman has said as much as well)
News 
Market Data 
Discover 
